ICICI Prudential MNC Fund - Growth - Direct Plan

  • Previous Nav

  • Net Change on 22-01-2021

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Direct Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The primary objective of the scheme is to generate long term capital appreciation by investing predominantly in equity and equity related securities within MNC space.However there can be no assurance or guarantee that the investment objective of the scheme would be achieved.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
NIFTY 50 - TRI N/A N/A N/A N/A N/A N/A
NIFTY MNC - TRI N/A N/A N/A N/A N/A N/A

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
SBI MAGNUM GLOBAL FUND - DIRECT PLAN -GROWTH Jan 01, 2013 19.34 5.41 12.45 1.28 4,325.60
Aditya Birla Sun Life MNC Fund - Growth - Direct Plan Jan 01, 2013 13.62 5.36 11.29 1.14 4,078.31
UTI - MNC Fund - Growth Option - Direct Jan 01, 2013 15.11 5.08 11.32 1.34 2,309.11

Fund Holdings as on 31-December-2020

  • Maruti Suzuki India Ltd.

  • TREPS

  • Bharti Airtel Ltd.

  • United Breweries Ltd.

  • Wipro Ltd.

  • Cummins India Ltd.

  • Sanofi India Ltd.

  • Net Current Assets

  • Vedanta Ltd.

  • Hindalco Industries Ltd.

  • Grindwell Norton Ltd.

  • Procter & Gamble Hygiene and Health Care Ltd.

  • Anheuser-Busch InBev

  • Oracle Financial Services Software Ltd.

  • Cyient Ltd.

  • Heidleberg Cement India Ltd.

  • Apollo Tyres Ltd.

  • Lyondellbasell Indu-CL A

  • Nestle India Ltd.

  • Siemens Ltd.

  • Fortis Healthcare Ltd.

  • HCL Technologies Ltd.

  • Ambuja Cements Ltd.

  • Sun Pharmaceutical Industries Ltd.

  • Tata Chemicals Ltd.

  • Colgate - Palmolive (India) Ltd.

  • Interglobe Aviation Ltd.

  • Tata Steel Ltd.

  • Hindustan Unilever Ltd.

  • Gillette India Ltd.

  • Glaxosmithkline Pharmaceuticals Ltd.

  • Torrent Pharmaceuticals Ltd.

  • Diageo plc

  • Raytheon Technologies Corp

  • Schaeffler India Ltd.

  • Hindustan Zinc Ltd.

  • Philip Morris Intl Inc

  • Timken India Ltd.

  • EIH Ltd.

  • Firstsource Solutions Ltd.

  • Birlasoft Ltd.

  • Northrop Grumman Corp

  • SAP SE (SAP)

  • Ralph Lauren Corporation

  • ITC Ltd.

  • Tata Motors Ltd. - DVR

  • Triveni Turbine Ltd.

View More
  • IT - Software

  • Miscellaneous

  • Automobiles - Passenger Cars

  • Metal - Non Ferrous

  • Pharmaceuticals & Drugs

  • Household & Personal Products

  • Telecommunication - Service Provider

  • Breweries & Distilleries

  • Cement & Construction Materials

  • Diesel Engines

  • Abrasives

  • Tyres & Allied

  • Consumer Food

  • Electric Equipment

  • Hospital & Healthcare Services

  • Bearings

  • Chemicals

  • Airlines

  • Steel & Iron Products

  • Hotel, Resort & Restaurants

  • BPO/ITeS

  • Cigarettes/Tobacco

  • Engineering - Industrial Equipments

View More

About ICICI Prudential MNC Fund

Scheme Analysis

ICICI Prudential MNC Fund is a Equity - Thematic Fund - MNC fund and belongs to ICICI Prudential Mutual Fund. It was launched on 17-Jun-2019 and currently has an AUM of ₹552.20 crore. ICICI Prudential MNC Fund is benchmarked against NIFTY 50 - TRI as primary index and NIFTY MNC - TRI as secondary index.

The NAV of ICICI Prudential MNC Fund ended up ₹0(0%)yesterday to ₹14.34.

Among its top 3 holdings the fund has exposure to Maruti Suzuki India Ltd., and

The ICICI Prudential MNC Fund is managed by Anish Tawakley and Vaibhav Dusad.

Fund House Contact

One BKC, A - Wing 13th Floor, Bandra Kurla Complex, Bandra (East) Mumbai - 400 051

+91 (22) 2652 5000
enquiry@icicipruamc.com
+91 (22) 2652 8100